|
|
|
|
|
|
|
|
|
Webinar: Beyond the Starting Material: Building a Path to GMP Manufacturing Success
|
Cell therapy manufacturing success starts long before the GMP cleanroom. Join experts from New York Blood Center Enterprises’ Comprehensive Cell Solutions (CCS) team to explore how starting material sourcing, collection strategies, process development, and technology transfer shape manufacturing outcomes. Gain practical insights for reducing variability, strengthening process robustness, and preparing cell therapy programs for clinical and commercial manufacturing. Click here to learn more.
|
|
|
|
|
|
|
|
Freeze Containers Protect High-Value Gene Therapy Batches
|
|
Case Study | W.L. Gore & Associates
|
With each batch of cell and gene therapy product representing a wealth of lifesaving potential, this biopharma company needed the right packaging solution for its relatively new therapy applications.
|
|
|
|
|
|
CNS Trials Are Difficult — Do They Have To Be?
|
|
Article | By Francesco Bibbiani and Marty Kraut, Ph.D., Avance Clinical
|
Clinical trials for central nervous system therapies face significant obstacles to approval, including subjective endpoints and complex patient selection. Consider a strategic approach for success.
|
|
|
|
|
|
|
|
By Cell & Gene: The Podcast
|
On episode 136 of Cell & Gene: The Podcast, Host Erin Harris welcomes back Dr. Panteli Theocharous, FIBMS, M.S., Ph.D., FRCPath to discuss why autoimmune CAR T is moving rapidly from an emerging concept toward a potentially transformative treatment approach.
|
|
|
|
|
|
|
|
|
|
|
|
CLINICAL TRIALS SOLUTIONS
|
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
|
